Showing results (1491-1500 of 1,763) with videos related to

Sort By:
Pageof 177
JACC. Cardiovascular Imaging|November 19, 2011
Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR RegistryOliver Bruder, Steffen Schneider, Detlev Nothnagel, et al.
Clinical Genetics|January 1, 1996
Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessmentA J Barnicoat, J L Bonneau, E Boyd, et al.
Oral Diseases|March 6, 2018
Telediagnosis of oral lesions in primary care: The EstomatoNet ProgramV C Carrard, M Roxo Gonçalves, J Rodriguez Strey, et al.
International Journal of Molecular Sciences|March 6, 2021
The Role of Tenascin C in Cardiac Reverse Remodeling Following Banding-Debanding of the Ascending AortaMireia Perera-Gonzalez, Attila Kiss, Philipp Kaiser, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2012
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancerKatsuyuki Hotta, Etsuji Suzuki, Massimo Di Maio, et al.
Cancer Research|January 2, 2009
Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillanceOlivia Simma, Eva Zebedin, Nina Neugebauer, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 22, 2016
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled TrialMartin R Grübler, Martin Gaksch, Katharina Kienreich, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 12, 2011
The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoningAdriano Chan, Daune L Crankshaw, Alexandre Monteil, et al.
The Laryngoscope|February 21, 2019
Multicenter randomized crossover trial evaluating the provox luna in laryngectomized subjectsChathura B B Ratnayake, Renske Fles, I Bing Tan, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2005
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic ratsBernhard Pilz, Erdenechimeg Shagdarsuren, Maren Wellner, et al.
Pageof 177